General Electric Co Healthcare Investor Day at the RSNA Annual Meeting Transcript
(presentation)
Good morning, everybody. What a great way to start with that video. Welcome to our GE Healthcare Investor Meeting, and especially thank you to those who braved the weather coming in from the East Coast and elsewhere to make it here. I know on some of you, it was not easy. So we appreciate it.
I'm Steve Winoker, VP of IR for GE, and I'm delighted to be in Chicago with the team here. We're joined by our Healthcare CEO, Kieran Murphy, and members of his leadership team upfront.
Before we start, I'd like to remind you that the presentation for today is available on our investor website. In the presentation, GE Healthcare, excluding biopharma financials and figures, reflect today's view of the business as internally reported within GE and of our best estimates prior to completion of the deal closing. We'll be saying very little about the biopharma business and deal today. As many of you know, Danaher is in the lead on the regulatory approvals. What we can say is that we remain on track for
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |